Skip to content
healthcare.dev
Get a free key

Diltiazem Hydrochloride EXTENDED RELEASE

NDC 68682-367, diltiazem hydrochloride, capsule, extended release, from Oceanside Pharmaceuticals.

Product NDC
68682-367
Status
Listed
Labeler
Oceanside Pharmaceuticals
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA020401
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68682-367 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE120 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
68682-367-906868203679090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68682-367-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/862d65cb-a732-4786-b569-bad2eaafddfd

Use it

Look up 68682-367 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68682-367 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68682-367. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.